(CRBG) Corebridge Financial - Ratings and Ratios
Annuities, Life Insurance, Retirement Plans, Investment Products
CRBG EPS (Earnings per Share)
CRBG Revenue
Description: CRBG Corebridge Financial
Corebridge Financial, Inc. is a leading provider of retirement solutions and insurance products in the United States, operating through four main segments: Individual Retirement, Group Retirement, Life Insurance, and Institutional Markets. The company offers a diverse range of products, including annuities, life insurance, and investment advisory services, catering to various customer needs.
From a business perspective, Corebridge Financials revenue streams are diversified across its segments, with the Individual Retirement segment likely generating significant revenue from fixed annuities and variable annuities. The Group Retirement segments open architecture recordkeeping platform and in-plan investment advisory services also contribute to revenue growth. Key Performance Indicators (KPIs) to monitor include the companys annuity sales, life insurance policy sales, and assets under management (AUM).
To evaluate Corebridge Financials financial performance, key metrics to analyze include revenue growth, net income margin, return on equity (RoE), and return on assets (RoA). The companys RoE of 5.73% indicates a relatively modest return on shareholder equity. Other important KPIs include the companys capital adequacy ratio, asset quality, and liquidity metrics. Additionally, the companys dividend yield and payout ratio are also worth examining to assess its attractiveness to income-seeking investors.
From a valuation perspective, Corebridge Financials price-to-earnings (P/E) ratio of 30.80x suggests a relatively high valuation compared to its earnings. However, the forward P/E ratio of 7.05x indicates expected earnings growth. To further assess the companys valuation, metrics such as price-to-book (P/B) ratio, enterprise value-to-EBITDA (EV/EBITDA) ratio, and dividend yield can be analyzed.
CRBG Stock Overview
| Market Cap in USD | 18,202m |
| Sub-Industry | Diversified Financial Services |
| IPO / Inception | 2022-09-15 |
CRBG Stock Ratings
| Growth Rating | 85.0% |
| Fundamental | 41.4% |
| Dividend Rating | 55.3% |
| Return 12m vs S&P 500 | 6.14% |
| Analyst Rating | 4.07 of 5 |
CRBG Dividends
| Dividend Yield 12m | 3.56% |
| Yield on Cost 5y | 7.09% |
| Annual Growth 5y | 25.99% |
| Payout Consistency | 58.5% |
| Payout Ratio | 18.3% |
CRBG Growth Ratios
| Growth Correlation 3m | 39.8% |
| Growth Correlation 12m | 73.1% |
| Growth Correlation 5y | 91.2% |
| CAGR 5y | 28.47% |
| CAGR/Max DD 5y | 0.81 |
| Sharpe Ratio 12m | 0.71 |
| Alpha | 2.42 |
| Beta | 1.372 |
| Volatility | 26.79% |
| Current Volume | 1565.2k |
| Average Volume 20d | 3383.9k |
| Stop Loss | 33.7 (-3.1%) |
| Signal | -1.08 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-337.0m TTM) > 0 and > 6% of Revenue (6% = 464.6m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -0.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 632.5% (prev 350.0%; Δ 282.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 1.68b > Net Income -337.0m (YES >=105%, WARN >=100%) |
| Net Debt (9.17b) to EBITDA (1.08b) ratio: 8.48 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (550.3m) change vs 12m ago -10.17% (target <= -2.0% for YES) |
| Gross Margin 94.50% (prev 36.01%; Δ 58.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.98% (prev 4.85%; Δ -2.86pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.59 (EBITDA TTM 1.08b / Interest Expense TTM 563.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.98
| (A) 0.12 = (Total Current Assets 58.44b - Total Current Liabilities 9.46b) / Total Assets 399.16b |
| (B) 0.04 = Retained Earnings (Balance) 17.67b / Total Assets 399.16b |
| (C) 0.00 = EBIT TTM 895.0m / Avg Total Assets 390.83b |
| (D) 0.02 = Book Value of Equity 7.04b / Total Liabilities 385.99b |
| Total Rating: 0.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.36
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 4.82% = 2.41 |
| 3. FCF Margin 21.67% = 5.42 |
| 4. Debt/Equity 1.68 = 1.23 |
| 5. Debt/Ebitda 19.15 = -2.50 |
| 6. ROIC - WACC -2.57% = -3.21 |
| 7. RoE -2.73% = -0.46 |
| 8. Rev. Trend -56.79% = -2.84 |
| 9. Rev. CAGR -29.60% = -2.50 |
| 10. EPS Trend -27.50% = -0.69 |
| 11. EPS CAGR -36.01% = -2.50 |
What is the price of CRBG shares?
Over the past week, the price has changed by -0.57%, over one month by -3.26%, over three months by +7.23% and over the past year by +24.15%.
Is Corebridge Financial a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRBG is around 38.48 USD . This means that CRBG is currently undervalued and has a potential upside of +10.67% (Margin of Safety).
Is CRBG a buy, sell or hold?
- Strong Buy: 6
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the CRBG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41.2 | 18.3% |
| Analysts Target Price | 35.3 | 1.6% |
| ValueRay Target Price | 41.7 | 20% |
Last update: 2025-08-18 02:03
CRBG Fundamental Data Overview
CCE Cash And Equivalents = 4.10b USD (Cash And Short Term Investments, last quarter)
P/E Forward = 7.1327
P/S = 1.1316
P/B = 1.4796
Beta = 0.956
Revenue TTM = 7.74b USD
EBIT TTM = 895.0m USD
EBITDA TTM = 1.08b USD
Long Term Debt = 11.25b USD (from longTermDebt, last quarter)
Short Term Debt = 9.46b USD (from shortTermDebt, last quarter)
Debt = 20.70b USD (Calculated: Short Term 9.46b + Long Term 11.25b)
Net Debt = 9.17b USD (from netDebt column, last quarter)
Enterprise Value = 34.81b USD (18.20b + Debt 20.70b - CCE 4.10b)
Interest Coverage Ratio = 1.59 (Ebit TTM 895.0m / Interest Expense TTM 563.0m)
FCF Yield = 4.82% (FCF TTM 1.68b / Enterprise Value 34.81b)
FCF Margin = 21.67% (FCF TTM 1.68b / Revenue TTM 7.74b)
Net Margin = -4.35% (Net Income TTM -337.0m / Revenue TTM 7.74b)
Gross Margin = 94.50% ((Revenue TTM 7.74b - Cost of Revenue TTM 426.0m) / Revenue TTM)
Tobins Q-Ratio = 4.94 (Enterprise Value 34.81b / Book Value Of Equity 7.04b)
Interest Expense / Debt = 0.66% (Interest Expense 137.0m / Debt 20.70b)
Taxrate = 21.41% (from yearly Income Tax Expense: 600.0m / 2.80b)
NOPAT = 703.4m (EBIT 895.0m * (1 - 21.41%))
Current Ratio = 6.18 (Total Current Assets 58.44b / Total Current Liabilities 9.46b)
Debt / Equity = 1.68 (Debt 20.70b / last Quarter total Stockholder Equity 12.30b)
Debt / EBITDA = 19.15 (Net Debt 9.17b / EBITDA 1.08b)
Debt / FCF = 12.34 (Debt 20.70b / FCF TTM 1.68b)
Total Stockholder Equity = 12.34b (last 4 quarters mean)
RoA = -0.08% (Net Income -337.0m, Total Assets 399.16b )
RoE = -2.73% (Net Income TTM -337.0m / Total Stockholder Equity 12.34b)
RoCE = 3.79% (Ebit 895.0m / (Equity 12.34b + L.T.Debt 11.25b))
RoIC = 2.89% (NOPAT 703.4m / Invested Capital 24.36b)
WACC = 5.46% (E(18.20b)/V(38.91b) * Re(11.07%)) + (D(20.70b)/V(38.91b) * Rd(0.66%) * (1-Tc(0.21)))
Shares Correlation 5-Years: -90.0 | Cagr: -3.89%
Discount Rate = 11.07% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 69.39% ; FCFE base≈2.26b ; Y1≈2.44b ; Y5≈2.99b
Fair Price DCF = 60.44 (DCF Value 32.56b / Shares Outstanding 538.7m; 5y FCF grow 8.53% → 3.0% )
Revenue Correlation: -56.79 | Revenue CAGR: -29.60%
Rev Growth-of-Growth: -36.11
EPS Correlation: -27.50 | EPS CAGR: -36.01%
EPS Growth-of-Growth: -96.45
Additional Sources for CRBG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle